AGX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Argan Inc. (AGX) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. Despite strong financial performance and a robust backlog, the stock is trading at a high valuation, insiders and hedge funds are selling significantly, and there is no recent positive news or trading signals to suggest an immediate entry point. Holding off for a better valuation or clearer signals is advisable.
The technical indicators show a bullish trend with moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram of 4.606. However, the RSI of 78.738 is in the neutral zone, suggesting no clear overbought or oversold condition. The stock is trading near its resistance level (R1: 453.123), which may limit further short-term upside.
The company has a strong $3B backlog providing visibility for the next 2-3 years. Financial performance in Q3 2026 showed growth in net income (+9.74% YoY), EPS (+8.50% YoY), and gross margin (+8.35% YoY).
Significant insider selling (+29217.07% last month) and hedge fund selling (+252.84% last quarter) indicate a lack of confidence from key stakeholders. Analysts have downgraded the stock to Hold, citing a top-tier valuation. No recent news or congress trading data is available to support a bullish sentiment.
In Q3 2026, revenue dropped by -2.28% YoY to $251.15M, but net income increased by 9.74% YoY to $30.74M. EPS grew by 8.50% YoY to 2.17, and gross margin improved by 8.35% YoY to 18.69%. Overall, the company demonstrated profitability growth despite a slight revenue decline.
Lake Street downgraded Argan to Hold from Buy with a price target of $325, up from $260. Analysts acknowledge strong execution and margins but highlight that the stock is trading at a high valuation on peak estimates.
